Paper19259318
Prognostic factors for squamous cell cancer of the anal canal.
Das P and 3 others. Gastrointest Cancer Res, 2008. Cited by 35 papers, by iCite.
Cite this record
ConductScience Library. Prognostic factors for squamous cell cancer of the anal canal. Papers, record 19259318. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19259318
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8874455 | Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. | Lancet | 1996 | https://conductscience.org/library/papers/8874455 | PubMed |
| 2 | 11598480 | HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients. | Dis Colon Rectum | 2001 | https://conductscience.org/library/papers/11598480 | PubMed |
| 3 | 8823332 | Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. | J Clin Oncol | 1996 | https://conductscience.org/library/papers/8823332 | PubMed |
| 4 | 16916475 | Local tumor control and toxicity in HIV-associated anal carcinoma treated with radiotherapy in the era of antiretroviral therapy. | Radiat Oncol | 2006 | https://conductscience.org/library/papers/16916475 | PubMed |
| 5 | 3698757 | Prognosis of cloacogenic and squamous cancers of the anal canal. | Dis Colon Rectum | 1986 | https://conductscience.org/library/papers/3698757 | PubMed |
| 6 | 16245310 | Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response. | Cancer | 2005 | https://conductscience.org/library/papers/16245310 | PubMed |
| 7 | 2376397 | Prognostic factors in anal squamous carcinoma: a multivariate analysis of clinical, pathological and flow cytometric parameters in 235 cases. | Histopathology | 1990 | https://conductscience.org/library/papers/2376397 | PubMed |
| 8 | 16938816 | Chemoradiotherapy in patients with anal cancer: impact of length of unplanned treatment interruption on outcome. | Acta Oncol | 2006 | https://conductscience.org/library/papers/16938816 | PubMed |
| 9 | 15719440 | Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. | Cancer | 2005 | https://conductscience.org/library/papers/15719440 | PubMed |
| 10 | 16028002 | Positron Emission Tomography for pretreatment staging and posttreatment evaluation in cancer of the anal canal. | Mol Imaging Biol | 2005 | https://conductscience.org/library/papers/16028002 | PubMed |
| 11 | 9559628 | Sphincter preservation with chemoradiation in anal canal carcinoma: abdominoperineal resection in selected cases? | Dis Colon Rectum | 1998 | https://conductscience.org/library/papers/9559628 | PubMed |
| 12 | 9336145 | Time-dose considerations in the treatment of anal cancer. | Int J Radiat Oncol Biol Phys | 1997 | https://conductscience.org/library/papers/9336145 | PubMed |
| 13 | 16396154 | Management of anal cancer in the HIV-positive population. | Oncology (Williston Park) | 2005 | https://conductscience.org/library/papers/16396154 | PubMed |
| 14 | 2599902 | Epidermoid carcinoma of the anal canal treatment results and prognostic variables in a series of 242 cases. | Int J Radiat Oncol Biol Phys | 1989 | https://conductscience.org/library/papers/2599902 | PubMed |
| 15 | 2724350 | Definitive irradiation and chemotherapy for radiosensitization in management of anal carcinoma: interim report on Radiation Therapy Oncology Group study no. 8314. | J Natl Cancer Inst | 1989 | https://conductscience.org/library/papers/2724350 | PubMed |
| 16 | 16626889 | FDG-PET/CT in the evaluation of anal carcinoma. | Int J Radiat Oncol Biol Phys | 2006 | https://conductscience.org/library/papers/16626889 | PubMed |
| 17 | 10435807 | Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer. | Radiother Oncol | 1999 | https://conductscience.org/library/papers/10435807 | PubMed |
| 18 | 9069302 | Conservative treatment by irradiation of epidermoid cancers of the anal canal: prognostic factors of tumoral control and complications. | Int J Radiat Oncol Biol Phys | 1997 | https://conductscience.org/library/papers/9069302 | PubMed |
| 19 | 11319280 | Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. | Am J Clin Oncol | 2001 | https://conductscience.org/library/papers/11319280 | PubMed |
| 20 | 15752894 | Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness. | Int J Radiat Oncol Biol Phys | 2005 | https://conductscience.org/library/papers/15752894 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39330009 | Factors Influencing Outcomes and Survival in Anal Cancer. | Curr Oncol | 2024 | https://conductscience.org/library/papers/39330009 | PubMed |
| 38464575 | Ectopic production of beta-hCG in anal cancer: A case report. | Clin Case Rep | 2024 | https://conductscience.org/library/papers/38464575 | PubMed |
| 36402828 | Influence of radiation treatment technique (IMRT vs. 3D-RT) on acute toxicity and prognostic factors for survival for anal cancer. | Sci Rep | 2022 | https://conductscience.org/library/papers/36402828 | PubMed |
| 35751111 | Leukocyte subtyping predicts for treatment failure and poor survival in anal squamous cell carcinoma. | BMC Cancer | 2022 | https://conductscience.org/library/papers/35751111 | PubMed |
| 35659632 | Prognostic factors for patients with anal cancer treated with conformal radiotherapy-a systematic review. | BMC Cancer | 2022 | https://conductscience.org/library/papers/35659632 | PubMed |
| 32803517 | Racial/Ethnic Disparities in Survival Among Women Diagnosed with Invasive Cancer of the Anal Canal: an Analysis of Surveillance, Epidemiology, and End Results (SEER) Data. | J Gastrointest Cancer | 2021 | https://conductscience.org/library/papers/32803517 | PubMed |
| 32781500 | Role of Immune Checkpoint Inhibitors in Gastrointestinal Malignancies. | J Clin Med | 2020 | https://conductscience.org/library/papers/32781500 | PubMed |
| 31559389 | Anal squamous cell carcinoma with metastasis to duodenum causing duodenal stricture and gastric outlet obstruction. | AME Case Rep | 2019 | https://conductscience.org/library/papers/31559389 | PubMed |
| 30662475 | Efficacy and tolerance of high-dose-rate brachytherapy boost after external radiotherapy in the treatment of squamous cell carcinoma of the anal canal. | J Contemp Brachytherapy | 2018 | https://conductscience.org/library/papers/30662475 | PubMed |
| 30627062 | Prognostic Significance of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Anal Squamous Cell Carcinoma: A Systematic Review and a Meta-Analysis. | Contrast Media Mol Imaging | 2018 | https://conductscience.org/library/papers/30627062 | PubMed |
| 29623585 | The effect of dose escalation for large squamous cell carcinomas of the anal canal. | Clin Transl Oncol | 2018 | https://conductscience.org/library/papers/29623585 | PubMed |
| 27923035 | Biomarkers in anal cancer: from biological understanding to stratified treatment. | Br J Cancer | 2017 | https://conductscience.org/library/papers/27923035 | PubMed |
| 27044498 | Genital invasion or perigenital spread may pose a risk of marginal misses for Intensity Modulated Radiotherapy (IMRT) in anal cancer. | Radiat Oncol | 2016 | https://conductscience.org/library/papers/27044498 | PubMed |
| 26186412 | Cancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning (LGBTQ) populations. | CA Cancer J Clin | 2015 | https://conductscience.org/library/papers/26186412 | PubMed |
| 24014082 | HIV positivity but not HPV/p16 status is associated with higher recurrence rate in anal cancer. | J Gastrointest Cancer | 2013 | https://conductscience.org/library/papers/24014082 | PubMed |
| 23184242 | [Curative radiotherapy in patients with anal cancer: clinical outcomes and prognostic factors in a single-institution experience]. | Radiol Med | 2013 | https://conductscience.org/library/papers/23184242 | PubMed |
| 22697293 | High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy. | Radiat Oncol | 2012 | https://conductscience.org/library/papers/22697293 | PubMed |
| 21063399 | Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review. | Br J Cancer | 2010 | https://conductscience.org/library/papers/21063399 | PubMed |
| 19231109 | Intensity-modulated radiation therapy for the treatment of squamous cell anal cancer with para-aortic nodal involvement. | Int J Radiat Oncol Biol Phys | 2009 | https://conductscience.org/library/papers/19231109 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CCNA2 | 890 | PubTator's text mining | https://conductscience.org/library/genes/890 | NCBI Gene |
| H3P16 | 644914 | PubTator's text mining | https://conductscience.org/library/genes/644914 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19259318
GET https://conductscience.org/api/papers/v1/19259318/references?page=2